查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881487

強度調製放射治療市場－全球產業規模、佔有率、趨勢、機會和預測，按放射類型、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Intensity Modulated Radiotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Radiation Type, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球調強放射治療市場規模為20.1億美元，預計2030年將以5.61%的複合年成長率成長至27.9億美元。調強放射治療（IMRT）是一種先進的放射治療技術，它透過調節眾多細小放射束的強度，將輻射精確地輸送到腫瘤部位，從而貼合腫瘤形狀並最大限度地減少對周圍健康組織的輻射暴露。該市場的成長主要受全球各類癌症發病率上升以及人們對更有效、毒性更小的治療方式（旨在提高患者生活品質）的需求不斷成長的驅動。

市場概覽
預測期 2026-2030
2024年市場規模 20.1億美元
2030年市場規模 27.9億美元
2025-2030年複合年成長率 5.61%
成長最快的細分市場 肺癌
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球調強放射治療市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依輻射類型（質子輻射、電子輻射、光子輻射、碳離子輻射）
    • 按最終使用者（醫院和診所、門診手術護理、其他）
    • 依應用領域（前列腺癌、肺癌、乳癌、腦癌、婦科癌症、胃腸道癌症、其他癌症）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美調強放射治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲調強放射治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區調強放射治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲調強放射治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲調強放射治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球調強放射治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems BV
  • Koninklijke Philips NV
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 22136

The Global Intensity Modulated Radiotherapy Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 5.61% to reach USD 2.79 Billion by 2030. Intensity Modulated Radiotherapy (IMRT) is an advanced radiation therapy technique that precisely delivers radiation to tumors by modulating the intensity of numerous small radiation beams, thereby conforming to the tumor shape and minimizing exposure to surrounding healthy tissues. The market's expansion is fundamentally driven by the escalating global incidence of various cancer types, coupled with increasing demand for effective and less toxic treatment modalities that improve patient quality of life.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 2.01 Billion
Market Size 2030USD 2.79 Billion
CAGR 2025-20305.61%
Fastest Growing SegmentLung Cancer
Largest MarketNorth America

Key Market Drivers

The global Intensity Modulated Radiotherapy market is significantly influenced by the escalating global incidence of cancer, which fundamentally drives the demand for advanced and precise treatment modalities. The rising number of new cancer diagnoses worldwide necessitates effective therapeutic options like IMRT to manage the growing patient population. According to the American Cancer Society, in April 2024, in its "Global Cancer Statistics, 2024" report, an estimated 20 million cancer cases were newly diagnosed in 2022, underscoring the substantial and expanding need for oncology services.

Key Market Challenges

The significant capital investment required for Intensity Modulated Radiotherapy (IMRT) equipment acquisition, installation, and ongoing maintenance directly impedes the growth of the global market. This substantial financial outlay creates a considerable barrier, especially for healthcare providers in developing economies where budgets are frequently constrained. The high initial purchase price of sophisticated IMRT systems, coupled with expenses for specialized facility infrastructure, comprehensive training for technical staff, and continuous servicing contracts, places a heavy burden on healthcare systems.

Key Market Trends

The shift towards hypofractionated Intensity Modulated Radiotherapy regimens represents a significant trend in the global market, driven by its ability to deliver higher radiation doses per fraction over a shorter treatment period. This approach enhances patient convenience by reducing the number of hospital visits and overall treatment duration, while potentially lowering healthcare costs and improving access to care. According to an ASTRO 2024 report, approximately 7% of patients with intermediate-risk prostate cancer in the U. S. received hypofractionated regimens, indicating a substantial adoption rate in this patient cohort. This widespread acceptance is further supported by clinical evidence.

Key Market Players

  • Siemens Healthineers AG
  • Accuray Incorporated
  • Elekta GmbH
  • Iba LLC
  • Hitachi, Ltd.
  • Mevion Medical Systems B.V.
  • Koninklijke Philips N.V.
  • Raysearch Laboratories AB
  • Brainlab AG
  • HD Biosciences Co., Ltd.

Report Scope:

In this report, the Global Intensity Modulated Radiotherapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intensity Modulated Radiotherapy Market, By Radiation Type:

  • Proton radiation
  • Electron radiation
  • Photon radiation
  • Carbon-lon radiation

Intensity Modulated Radiotherapy Market, By End User:

  • Hospital & Clinics
  • Ambulatory Surgical care
  • Others

Intensity Modulated Radiotherapy Market, By Application:

  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Brain cancer
  • Gynecological cancers
  • Gastrointestinal cancers
  • Other cancers

Intensity Modulated Radiotherapy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Intensity Modulated Radiotherapy Market.

Available Customizations:

Global Intensity Modulated Radiotherapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intensity Modulated Radiotherapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Radiation Type (Proton radiation, Electron radiation, Photon radiation, Carbon-lon radiation)
    • 5.2.2. By End User (Hospital & Clinics, Ambulatory Surgical care, Others)
    • 5.2.3. By Application (Prostate cancer, Lung cancer, Breast cancer, Brain cancer, Gynecological cancers, Gastrointestinal cancers, Other cancers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Intensity Modulated Radiotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Radiation Type
    • 6.2.2. By End User
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intensity Modulated Radiotherapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Radiation Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Intensity Modulated Radiotherapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Radiation Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Intensity Modulated Radiotherapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Radiation Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Application

7. Europe Intensity Modulated Radiotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Radiation Type
    • 7.2.2. By End User
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intensity Modulated Radiotherapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Radiation Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Application
    • 7.3.2. France Intensity Modulated Radiotherapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Radiation Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Intensity Modulated Radiotherapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Radiation Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Intensity Modulated Radiotherapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Radiation Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Intensity Modulated Radiotherapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Radiation Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Application

8. Asia Pacific Intensity Modulated Radiotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Radiation Type
    • 8.2.2. By End User
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intensity Modulated Radiotherapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Radiation Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Application
    • 8.3.2. India Intensity Modulated Radiotherapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Radiation Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Intensity Modulated Radiotherapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Radiation Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Intensity Modulated Radiotherapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Radiation Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Intensity Modulated Radiotherapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Radiation Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Application

9. Middle East & Africa Intensity Modulated Radiotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Radiation Type
    • 9.2.2. By End User
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intensity Modulated Radiotherapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Radiation Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Intensity Modulated Radiotherapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Radiation Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Intensity Modulated Radiotherapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Radiation Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Application

10. South America Intensity Modulated Radiotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Radiation Type
    • 10.2.2. By End User
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intensity Modulated Radiotherapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Radiation Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Intensity Modulated Radiotherapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Radiation Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Intensity Modulated Radiotherapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Radiation Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intensity Modulated Radiotherapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens Healthineers AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Accuray Incorporated
  • 15.3. Elekta GmbH
  • 15.4. Iba LLC
  • 15.5. Hitachi, Ltd.
  • 15.6. Mevion Medical Systems B.V.
  • 15.7. Koninklijke Philips N.V.
  • 15.8. Raysearch Laboratories AB
  • 15.9. Brainlab AG
  • 15.10. HD Biosciences Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer